
About NCK Pharma Solution Private Limited
Data last updated:
NCK Pharma Solution Private Limited is a private limited company based in Delhi, India. It operates in the educational support services segment of the education and learning sector. It was incorporated on 30 June 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2009PTC191741. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saikat Roy and Kalyan Karmakar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at X/847 Chand Mohalla Street No. 11 Gandhi Nagar, Delhi, India – 110031.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.42 Lakh, a decline of 74% compared to the previous year. For the same year it recorded a net loss of ₹28,945 (net margin -20.3%) and EBITDA of ₹1,404 (EBITDA margin 1%). Revenue has declined at a compounded annual rate (CAGR) of 28% over three years and 22% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nckpharma.com.
Company details
Contact details
NCK Pharma Solution Private Limited's registered office is in Delhi, Delhi. Its website is nckpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressX/847 Chand Mohalla Street No. 11 Gandhi Nagar, Delhi, India – 110031
- IndustryEducation & Learing, Educational Support Services
To see the full contact details of NCK Pharma Solution Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of NCK Pharma Solution Private Limited
FY 2024 filings availableNCK Pharma Solution Private Limited reported revenue of ₹1.42 Lakh (down 74% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 22% over five years, including a 74% fall in the latest year. EBITDA fell 95% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.42 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1,404 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹28,945 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | -20.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of NCK Pharma Solution Private Limited, buy the company report.
Board of directors of NCK Pharma Solution Private Limited
NCK Pharma Solution has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saikat Roy | Director | 30 Jun 2009 | 17 Years 4 Months | Current |
| Kalyan Karmakar | Director | 30 Jun 2009 | 17 Years 4 Months | Current |
Auditor
NCK Pharma Solution Private Limited is audited by KASHYAP SIKDAR AND COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KASHYAP SIKDAR AND COMPANY | FY 2023 | 0016253N |
Shareholding
The shareholding of NCK Pharma Solution Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of NCK Pharma Solution Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving NCK Pharma Solution Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for NCK Pharma Solution Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
NCK Pharma Solution has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of NCK Pharma Solution Private Limited, buy the company report.
Recent activity
NCK Pharma Solution Private Limited has 3 board changes on record since 2009: 2 appointments and 1 cessation. The latest: Sudip Kumar Dutta ceased to be Director on 16 Aug 2012.
Frequently asked questions
NCK Pharma Solution is an active private limited company based in Delhi, India. The company works in educational support services, within the education and learning industry. It was incorporated on 30 June 2009 (17+ years old) and is registered under CIN U74900DL2009PTC191741.
NCK Pharma Solution has 2 current directors:
- Saikat Roy - Director
- Kalyan Karmakar - Director
The latest financial statements of NCK Pharma Solution on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. NCK Pharma Solution has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of NCK Pharma Solution is U74900DL2009PTC191741. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
NCK Pharma Solution was incorporated on 30 June 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
Sudip Kumar Dutta ceased to be Director on 16 Aug 2012. Kalyan Karmakar was appointed as Director on 30 Jun 2009. Saikat Roy was appointed as Director on 30 Jun 2009.
NCK Pharma Solution can be reached through the website nckpharma.com. Its registered office is in Delhi, India.
The registered office of NCK Pharma Solution is at X847 Chand Mohalla Street No. 11 Gandhi Nagar, Delhi, India – 110031.
NCK Pharma Solution operates in the education and learning industry, in the educational support services segment.

